CRT 2025

Late-Breaking Clinical Trials Endovascular

One-Year Outcomes of the Prospective, Multi-Center, Single-Arm Study of the 355-nm Laser for Treatment of Below-the-Knee Arteries | Final Results of the Auryon BTK

Speaker(s)

• 

  Nicolas W. Shammas, MD, MS

  Founder, President and Research Director
  Midwest Cardiovascular Research Foundation
  Davenport, Iowa, United States

  No relationships to disclose